Ethnic inequalities in acute myocardial infarction hospitalization rates among young and middle-aged adults in Northern Italy: high risk for South Asians

2017 ◽  
Vol 13 (2) ◽  
pp. 177-182 ◽  
Author(s):  
Ugo Fedeli ◽  
Laura Cestari ◽  
Eliana Ferroni ◽  
Francesco Avossa ◽  
Mario Saugo ◽  
...  
2021 ◽  
Vol 23 (Supplement_G) ◽  
Author(s):  
Francesca Aste ◽  
Mattia Biddau ◽  
Maria Francesca Marchetti ◽  
Enrica Garau ◽  
Carlo Piga ◽  
...  

Abstract Aims During the COVID-19 pandemic, hospitalization rates for acute myocardial infarction (AMI) decreased worldwide. The aim of the study is to evaluate the impact of the COVID-19 pandemic on the admission rate for AMI to our academic hospital, to monitor the trend during the reopening phase and to evaluate if whether changes in air pollution may have influenced hospitalization rates for AMI in Sardinia and Northern Italy. Methods and results We compared the admission rate for AMI in our department and, by analysing the density of nitrogen dioxide (1/cm2), the state of air pollution in Sardinia and Northern Italy in different periods: the national lockdown (9 March–3 May 2020), the 8 weeks before the start of the lockdown, the 8 weeks after the end of the lockdown and the corresponding time period in 2019 (from 9 March to 3 May 2019). A marked decline in AMI admissions was observed during the lockdown period in comparison with the 8 weeks before the start of the lockdown (−47%, 95% CI: 37.5–56.7, P < 0.0001) and the corresponding period in 2019 (−52.8%, 95% CI: 43–65, P < 0.0001). There was a significant reduction in hospitalizations for NSTEMI during the lockdown period in comparison with the 8 weeks before the start of lockdown (−71.8%, 95% CI: 62.3–79.6, P < 0.0001) and the corresponding time period in 2019 (−70.5%, 95% CI: 60.9–78.5, P < 0.0001). Similar trends were seen in the group of STEMI patients, but the fall in admissions was less than that of NSTEMI patients. During the lockdown period, the hospitalizations for STEMI fell by 31.5% (95% CI: 23.2–41.4, P = 0.19) and 49% (95% CI: 39.4–58.6, 47 vs. 24 admissions, P = 0.009) in comparison to the 8 weeks before the start of lockdown and the corresponding period in 2019, respectively. We observed a rise in AMI admissions during the 8 weeks after the lockdown (+47%, 95% CI: 37.5–56.7, P < 0.0001), for both NSTEMI (+71.2%, 95% CI: 61.7–79.1, P < 0.0001) and STEMI (+33.4%, 95% CI: 24.9–43.1, P = 0.15). In Sardinia the relative change in nitrogen dioxide density during the time of lockdown was negligible with little or no impact on the environment (−19%, 95% CI: 12.5–27.7, P = 0.65), if we consider it occurred within a range of very low values of nitrogen dioxide (11.5 ± 3 e 14.1 ± 5 μmol/m2). In contrast, in Northern Italy during the lockdown there was a marked decrease in NO2 concentration in comparison with the 8 weeks before the start of lockdown (−53%, 95% CI: 43–62.4, 25.1 ± 16.2 e 54.2 ± 43.5 μmol/m2, P < 0.0001). Conclusions Since air pollution did not change substantially in our region, the environment factor cannot explain the decline in the number of admissions for AMI we recorded during the lockdown. Fear of contagion is the most plausible reason for the drop of hospitalizations for AMI during the lockdown period.


Circulation ◽  
2015 ◽  
Vol 131 (7) ◽  
pp. 614-623 ◽  
Author(s):  
Xiao Xu ◽  
Haikun Bao ◽  
Kelly Strait ◽  
John A. Spertus ◽  
Judith H. Lichtman ◽  
...  

1978 ◽  
Vol 41 (2) ◽  
pp. 197-203 ◽  
Author(s):  
Karl T. Weber ◽  
Joseph S. Janicki ◽  
Richard O. Russell ◽  
Charles E. Rackley ◽  
H.J.C. Swan ◽  
...  

Author(s):  
Mariana F Lobo ◽  
Vanessa Azzone ◽  
Luis Azevedo ◽  
Armando Teixeira-Pinto ◽  
Jose Pereira Miguel ◽  
...  

Objectives: Because inter- and intra-country variations in the adoption of medical technologies exist, international comparative studies provide an opportunity to infer technology effectiveness. Few studies have characterized recent trends in acute myocardial infarction (AMI) management between countries. Methods: Repeated cross-sectional observational cohorts of hospitalized adults aged ≥20 years discharged between January 2000 and December 2010. We identified new AMI hospitalizations using a US national 20% inpatient sample and a 100% inpatient sample in all Portuguese public sector hospitals. Age, sex, comorbidities, and median length of stay (interquartile range [IQR]) were determined. Annual age-sex adjusted hospitalization rates (HR) for AMI, in-hospital procedures, and in-hospital mortality were directly standardized to the 2010 US population. Intra-country (2010 relative to 2000) and inter-country in 2010 (Portugal [PT] relative to US) rate ratios [RR] were estimated. Findings: We identified 1476808 AMI US hospitalizations and 126314 Portugal hospitalizations between 2000 and 2010. Portuguese patients were more male, younger, and had fewer comorbidities compared to US patients (Table). The age-sex adjusted AMI HR decreased from 21 per 1000 person-years to 15 in the US (RR=0.70; 95% CI = [0.70, 0.71]) but increased in PT (14 to 15 per 1000, RR = 1.17 [1.14, 1.21]). While crude procedure rates were uniformly lower in PT, only CABG rates differed after standardization (2010: RR=0.19 [0.14, 0.26]). PCI use increased annually in both countries and decreased for CABG in the US only (102 to 79, RR=0.77 [0.73, 0.81]). Standardized in-hospital mortality decreased within-country (US: 44 to 29 per 1000, RR= 0.65 [0.60, 0.72]; PT: 93 to 62 per 1000, RR= 0.67 [0.44, 1.00]). In 2010, PT mortality was twice that in the US. Conclusions: AMI hospitalization rates and use of medical technologies are higher in the US compared to Portugal. However, standardized rates reveal only CABG surgery rates differ significantly between the two countries. Outcomes, measured by hospital mortality and LOS, are generally better in the U.S. Inter-country disparities may be a consequence of differential use of technologies, differences in AMI epidemiology, patient risk, or quality of hospital billing data.


2020 ◽  
Vol 16 (S10) ◽  
Author(s):  
Rebecca West ◽  
Ramit Ravona‐Springer ◽  
Inbal Sharvit‐Ginon ◽  
Sapir Golan ◽  
Anthony Heymann ◽  
...  

2018 ◽  
Vol 26 (4) ◽  
pp. 411-419 ◽  
Author(s):  
Victoria Tea ◽  
Marc Bonaca ◽  
Chekrallah Chamandi ◽  
Marie-Christine Iliou ◽  
Thibaut Lhermusier ◽  
...  

Background Full secondary prevention medication regimen is often under-prescribed after acute myocardial infarction. Design The purpose of this study was to analyse the relationship between prescription of appropriate secondary prevention treatment at discharge and long-term clinical outcomes according to risk level defined by the Thrombolysis In Myocardial Infarction (TIMI) Risk Score for Secondary Prevention (TRS-2P) after acute myocardial infarction. Methods We used data from the 2010 French Registry of Acute ST-Elevation or non-ST-elevation Myocardial Infarction (FAST-MI) registry, including 4169 consecutive acute myocardial infarction patients admitted to cardiac intensive care units in France. Level of risk was stratified in three groups using the TRS-2P score: group 1 (low-risk; TRS-2P=0/1); group 2 (intermediate-risk; TRS-2P=2); and group 3 (high-risk; TRS-2P≥3). Appropriate secondary prevention treatment was defined according to the latest guidelines (dual antiplatelet therapy and moderate/high dose statins for all; new-P2Y12 inhibitors, angiotensin-converting-enzyme inhibitor/angiotensin-receptor-blockers and beta-blockers as indicated). Results Prevalence of groups 1, 2 and 3 was 46%, 25% and 29% respectively. Appropriate secondary prevention treatment at discharge was used in 39.5%, 37% and 28% of each group, respectively. After multivariate adjustment, evidence-based treatments at discharge were associated with lower rates of major adverse cardiovascular events (death, re-myocardial infarction or stroke) at five years especially in high-risk patients: hazard ratio = 0.82 (95% confidence interval: 0.59–1.12, p = 0.21) in group 1, 0.74 (0.54–1.01; p = 0.06) in group 2, and 0.64 (0.52–0.79, p < 0.001) in group 3. Conclusions Use of appropriate secondary prevention treatment at discharge was inversely correlated with patient risk. The increased hazard related to lack of prescription of recommended medications was much larger in high-risk patients. Specific efforts should be directed at better prescription of recommended treatment, particularly in high-risk patients.


Author(s):  
Jie Chang ◽  
Qiuju Deng ◽  
Moning Guo ◽  
Majid Ezzati ◽  
Jill Baumgartner ◽  
...  

Acute myocardial infarction (AMI) poses a serious disease burden in China, but studies on small-area characteristics of AMI incidence are lacking. We therefore examined temporal trends and geographic variations in AMI incidence at the township level in Beijing. In this cross-sectional analysis, 259,830 AMI events during 2007–2018 from the Beijing Cardiovascular Disease Surveillance System were included. We estimated AMI incidence for 307 consistent townships during consecutive 3-year periods with a Bayesian spatial model. From 2007 to 2018, the median AMI incidence in townships increased from 216.3 to 231.6 per 100,000, with a greater relative increase in young and middle-aged males (35–49 years: 54.2%; 50–64 years: 33.2%). The most pronounced increases in the relative inequalities was observed among young residents (2.1 to 2.8 for males and 2.8 to 3.4 for females). Townships with high rates and larger relative increases were primarily located in Beijing’s northeastern and southwestern peri-urban areas. However, large increases among young and middle-aged males were observed throughout peri-urban areas. AMI incidence and their changes over time varied substantially at the township level in Beijing, especially among young adults. Targeted mitigation strategies are required for high-risk populations and areas to reduce health disparities across Beijing.


Sign in / Sign up

Export Citation Format

Share Document